About Apothkary
Apothkary is a company based in Falls Church (United States) founded in 2018. It operates as a D2C and B2C. Apothkary has raised $11.2 million across 2 funding rounds from investors including Shiseido. Apothkary offers products and services including Blue Burn, Mindcraft, and Sugar Kick. Apothkary operates in a competitive market with competitors including AmerisourceBergen, Renee, Immune Control, Atlantic Biologicals and Cencora, among others.
- Headquarter Falls Church, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Apothékary Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.2 M (USD)
in 2 rounds
-
Latest Funding Round
$8 M (USD), Seed
Nov 26, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Apothkary
Apothkary offers a comprehensive portfolio of products and services, including Blue Burn, Mindcraft, and Sugar Kick.
Tincture targets stress hormones to support weight and craving management.
Enhances focus, mood, and brain health with herbal ingredients.
Helps mitigate blood sugar spikes and reduce cravings naturally.
Funding Insights of Apothkary
Apothkary has successfully raised a total of $11.2M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $8 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Apothkary
Apothkary has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Shiseido.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Skincare, makeup, and suncare products are offered by Shiseido.
|
Locked | Locked | Locked |
Investor details for Apothkary
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apothkary
Investment portfolio details for Apothkary
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Apothkary
Detailed financials for Apothkary
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apothkary Comparisons
Peer comparison for Apothkary
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apothkary
Apothkary operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Renee, Immune Control, Atlantic Biologicals and Cencora, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Diversified drugs are distributed by Renee in the United States.
|
|
| Locked | Locked | Locked |
Limited information available
|
|
| Locked | Locked | Locked |
Distributor of pharmaceutical products
|
|
| Locked | Locked | Locked |
Clinical trial logistics and biopharma outsourcing services are provided globally.
|
Detailed competitors of Apothkary
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apothkary
Complete news archive for Apothkary
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apothkary
Apothkary was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Apothkary is headquartered in Falls Church, United States. It is registered at Falls Church, Virginia, United States.
Apothkary is a funded company, having raised a total of $11.2M across 2 funding rounds to date.
Apothékary specializes in herbal medicine, providing tinctures and supplements made from natural ingredients to address stress, metabolism, and mental clarity. They operate an online platform for direct sales, offering bundles and personalized plans. Based in the United States, they serve consumers seeking natural alternatives, with products available at retailers like Ulta and Sprouts for everyday health needs.
Apothkary's top competitors include AmerisourceBergen, AvKARE and Cencora.
Apothkary offers Blue Burn, Mindcraft, and Sugar Kick.
Apothkary has 1 investor. Key investors include Shiseido.